Particularly in patients with t(8;21), inv(16), or chromosome 11/ KMT2A abnormalities, evaluating for the presence of MS may be significant in considering therapeutic approaches.
← all excerpts
Pediatric Myeloid Sarcoma, More than Just a Chloroma: A Review of Clinical Presentations, Significance, and Biology.
1
—
—